Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer.

Authors: Hua, Xiaohui; Xu, Jiheng; Deng, Xu; Xu, Jiawei; Li, Jingxia; Zhu, David Q; Zhu, Junlan; Jin, Honglei; Tian, Zhongxian; Huang, Haishan; Zhao, Qin-Shi; Huang, Chuanshu

Published In Cancer Lett, (2018 11 01)

Abstract: ChlA-F is a novel conformation-derivative of Cheliensisin A, styryl-lactone isolates that show potent anti-tumor potential in vivo and vitro. However, the anti-cancer activity and its potential mechanisms underlying ChlA-F action have never been explored. In the present study, we evaluated the potency of ChlA-F on autophagy-mediated anchorage-independent growth inhibition in human high-grade invasive bladder cancer (BC) cells. We found that ChlA-F treatment significantly inhibited anchorage-independent growth of human BC cells by inducing autophagy in a Sestrin-2 (SESN2)-dependent fashion. Our results revealed that ChlA-F treatment specifically induced SESN2 expression via increasing its transcription and mRNA stability. On one hand, ChlA-F treatment markedly attenuated Dicer protein abundance, in turn abolishing miR-27a maturation and further relieving miR-27a binding directly to SESN2 mRNA 3'UTR, thereby promoting SESN2 mRNA stabilization. On the other hand, ChlA-F treatment promoted Sp1 abundance and consequently mediated SESN2 transcription. These results demonstrate that its activation of the autophagic pathway through specifically promoting SESN2 expression mediates the anti-cancer effect of ChlA-F, which offers insights into the novel anti-cancer effect of ChlA-F on BC, as well as providing therapeutic alternatives against human BC.

PubMed ID: 30118841 Exiting the NIEHS site

MeSH Terms: 3' Untranslated Regions/genetics; Antineoplastic Agents/chemistry; Antineoplastic Agents/pharmacology*; Autophagy/drug effects*; Autophagy/genetics; Cell Line; Cell Line, Tumor; DEAD-box RNA Helicases/genetics; DEAD-box RNA Helicases/metabolism; Epoxy Compounds/chemistry; Epoxy Compounds/pharmacology; Gene Expression Regulation, Neoplastic/drug effects*; Humans; Lactones/chemistry; Lactones/pharmacology*; MicroRNAs/genetics; Molecular Structure; Nuclear Proteins/genetics*; Nuclear Proteins/metabolism; Pyrones/chemistry; Pyrones/pharmacology; RNA Stability/drug effects; RNA Stability/genetics; Ribonuclease III/genetics; Ribonuclease III/metabolism; Up-Regulation/drug effects; Urinary Bladder Neoplasms/drug therapy; Urinary Bladder Neoplasms/genetics*; Urinary Bladder Neoplasms/metabolism

to Top